| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0032 | 1 |